Brenntag announces new agreement with Corbion for Animal Nutrition in Belgium, The Netherlands and France

Chief Financial Officer Georg Müller to depart earlier from the Board of Management of Brenntag SE

Brenntag SE appoints Dr Kristin Neumann to the Management Board as CFO as of April 1, 2022

Brenntag’s Pharma section signs exclusive agreement for health-promoting product line Akovita ELIP in EMEA

Brenntag expands distribution agreement with performance additives leader SI Group for EMEA

Brenntag achieved outstanding results in the third quarter 2021 in still persisting exceptional market conditions

Brenntag Food & Nutrition opens digital doors for its first Global Virtual Nutrition Event

Brenntag successfully places benchmark bond for Eur 500 Million as part of a new "Dept Issuance Programme"

Brenntag SE is included in the German benchmark index DAX

Brenntag achieved excellent results in an exceptional market environment in the second quarter 2021

Brenntag General Shareholders' Meeting approves tenth dividend increase in a row

Brenntag achieves very strong results in first quarter 2021 by prudently navigating through fast changing market conditions

Brenntag shows strong performance in the extraordinary year 2020 that underlines the resilience of its business model

Brenntag with strong performance in the third quarter of 2020

Brenntag will implement global transformation program to position the Group for sustainable organic earnings growth